GlassScriptPhysician profile
Charles Larnard
NPI 1700094877
$2,349.03
in general payments reported to CMS, 2019-2025
7 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.36 · 2022: $342 · 2023: $371 · 2024: $554 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,966.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,070.69 | 2022-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Getinge USA Sales, LLC | $515.56 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $336.17 | 2021-2025 | Mitris Resilia Mitral Valve, Konect Resilia |
| Zimmer Biomet Holdings, INC. | $166.33 | 2025 | Myo/Wire, Sternalock |
| Abbott Laboratories | $109.95 | 2023 | Portico |
| Medtronic, INC. | $90.18 | 2025 | Avalus |
| Ethicon US, LLC | $60.15 | 2022-2024 | Surgicel Nu-Knit, Enseal, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Larnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.